Direkt zum Inhalt
Merck
  • Comprehensive untargeted lipidomic analysis using core-shell C30 particle column and high field orbitrap mass spectrometer.

Comprehensive untargeted lipidomic analysis using core-shell C30 particle column and high field orbitrap mass spectrometer.

Journal of chromatography. A (2016-03-02)
Mónica Narváez-Rivas, Qibin Zhang
ZUSAMMENFASSUNG

The goal of untargeted lipidomics is to have high throughput, yet comprehensive and unambiguous identification and quantification of lipids. Novel stationary phases in LC separation and new mass spectrometric instruments capable of high mass resolving power and faster scanning rate are essential to achieving this goal. In this work, 4 reversed phase LC columns coupled with a high field quadrupole orbitrap mass spectrometer (Q Exactive HF) were thoroughly compared using complex lipid standard mixture and rat plasma and liver samples. A good separation of all lipids was achieved in 24min of gradient. The columns compared include C30 and C18 functionalization on either core-shell or totally porous silica particles, with size ranging from 1.7 to 2.6μm. Accucore C30 column showed the narrowest peaks and highest theoretical plate number, and excellent peak capacity and retention time reproducibility (<1% standard deviation). As a result, it resulted in 430 lipid species identified from rat plasma and rat liver samples with highest confidence. The high resolution offered by the up-front RPLC allowed discrimination of cis/trans isomeric lipid species, and the high field orbitrap mass spectrometer afforded the clear distinction of isobaric lipid species in full scan MS and the unambiguous assignment of sn-positional isomers for lysophospholipids in MS/MS. Taken together, the high efficiency LC separation and high mass resolving MS analysis are very promising tools for untargeted lipidomics analysis.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Avanti
18:1 (Δ9-Cis) PE (DOPE), Avanti Polar Lipids
Avanti
14:0 Lyso PG, Avanti Polar Lipids
Avanti
18:1 PA, Avanti Polar Lipids
Avanti
24:1 SM, Avanti Polar Lipids, powder
Avanti
12:0 SM (d18:1/12:0), Avanti Polar Lipids 860583P, powder
Avanti
16:0-18:1 PI, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol (ammonium salt), powder
Avanti
C12 Ceramide (d18:1/12:0), Avanti Polar Lipids
Avanti
C18(Plasm)-18:1 PE, Avanti Polar Lipids
Avanti
C18(Plasm)-18:1 PC, Avanti Polar Lipids
Avanti
18:1 Lyso PE, 1-oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine, chloroform
Avanti
22:6 PE, 1,2-didocosahexaenoyl-sn-glycero-3-phosphoethanolamine, chloroform
Avanti
C18(Plasm)-20:4 PC, 1-(1Z-octadecenyl)-2-arachidonoyl-sn-glycero-3-phosphocholine, chloroform
Avanti
12:0 PE, 1,2-dilauroyl-sn-glycero-3-phosphoethanolamine, powder
Avanti
22:6 PG, Avanti Polar Lipids 840492C
Avanti
14:0 Lyso PC, 1-myristoyl-2-hydroxy-sn-glycero-3-phosphocholine, chloroform
Avanti
22:0 Lyso PC, 1-behenoyl-2-hydroxy-sn-glycero-3-phosphocholine, chloroform
Avanti
18:1 Lyso PG, 1-oleoyl-2-hydroxy-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt), chloroform
Avanti
16:0 Lyso PI, 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt), powder
Avanti
22:1 (Cis) PC, 1,2-dierucoyl-sn-glycero-3-phosphocholine, chloroform
Avanti
20:4 Lyso PI, 1-arachidonoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt), powder
Avanti
18:1 Lyso PS, 1-oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine (sodium salt), chloroform